Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Bases de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Aquat Toxicol ; 79(1): 41-8, 2006 Aug 12.
Artigo em Inglês | MEDLINE | ID: mdl-16782212

RESUMO

One of the goals of environmental risk assessment (ERA) is to understand effects of toxicant exposure on individual organisms and populations. We hypothesized that toxicant exposure can reduce genetic diversity and alter genotype composition, which may ultimately lead to a reduction in the average fitness of the exposed population. To test this hypothesis, we exposed a copepod, Nitocra psammophila, to a toxic reference compound and assayed resulting alterations in genetic structure, i.e. expected heterozygosity and percent polymorphic loci, as well as other population- and fitness-related measures, i.e. population abundance, demographic structure and juvenile growth. The copepods were exposed to 0.11-1.1 microg of the pentabromo-substituted diphenyl ether (BDE-47) mg(-1) freeze-dried algae for 24 days (i.e. >1 generation). There was no significant decline in total population abundance. However, there were significant alterations in population structure, manifested as diminished proportion of nauplii and increased proportion of copepodites. In addition, individual RNA content in copepodites decreased significantly in exposed individuals, indicating declined growth. Finally, in the exposed populations, heterozygosity was lower and genotype composition was altered compared to the controls. These results therefore confirm the hypothesized reduction in overall genetic variability resulting from toxicant exposure. Multilevel approaches, such as the one used in the present study, may help unravel subtle effects on the population level, thus increasing the predictive capacity of future ERA.


Assuntos
Copépodes/efeitos dos fármacos , Exposição Ambiental , Retardadores de Chama/toxicidade , Variação Genética/efeitos dos fármacos , Éteres Fenílicos/toxicidade , Bifenil Polibromatos/toxicidade , Animais , Copépodes/genética , DNA/análise , Primers do DNA/química , Demografia , Expressão Gênica/efeitos dos fármacos , Crescimento/efeitos dos fármacos , Éteres Difenil Halogenados , Estágios do Ciclo de Vida/efeitos dos fármacos , Masculino , Reação em Cadeia da Polimerase/métodos , Polimorfismo Genético/efeitos dos fármacos , RNA/análise , Medição de Risco
2.
Ecotoxicol Environ Saf ; 63(2): 324-35, 2006 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-16406525

RESUMO

New regulations, in particular the new European chemicals legislation (REACH), will increase the demands on environmental risk assessment (ERA). The requirements on efficient ecotoxicological testing systems are summarized, and 10 major issues for the improvement of ERA practices are discussed, namely: (1) the choice of representative test species, (2) the development of test systems that are relevant for ecosystems in different parts of the world, (3) the inclusion of sensitive life stages in test systems, (4) the inclusion of endpoints on genetic variation in populations, (5) using mechanistic understanding of toxic effects to develop more informative and efficient test systems, (6) studying disruption in invertebrate endocrine mechanisms, that may differ radically from those we know from vertebrates, (7) developing standardized methodologies for testing of poorly water-soluble substances, (8) taking ethical considerations into account, in particular by reducing the use of vertebrates in ecotoxicological tests, (9) using a systematic (statistical) approach in combination with mechanistic knowledge to combine tests efficiently into testing systems, and (10) developing ERA so that it provides the information needed for precautionary decision-making.


Assuntos
Poluentes Ambientais/toxicidade , Animais , Conservação dos Recursos Naturais , Ecologia , Medição de Risco , Testes de Toxicidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA